Risk Factors for Tumor Lysis Syndrome (TLS) In Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Cyclin Dependent Kinase Inhibitor, Flavopiridol

被引：0
|
作者：
Blum, Kristie A. [1 ]
Ruppert, Amy S. [1 ]
Woyach, Jennifer A. [1 ]
Jones, Jeffrey A. [1 ]
Andritsos, Leslie [1 ]
Flynn, Joseph M. [1 ]
Rovin, Brad [1 ]
Villalona-Calero, Miguel [1 ]
Ji, Jia [1 ]
Phelps, Mitchell [1 ]
Johnson, Amy J. [1 ]
Greyer, Michael R. [1 ]
Byrd, John C. [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：596 / 597
页数：2
相关论文
共 50 条
  • [41] Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia
    Chen, Rong
    Wierda, William G.
    Chubb, Sherri
    Hawtin, Rachael E.
    Fox, Judith A.
    Keating, Michael J.
    Gandhi, Varsha
    Plunkett, William
    BLOOD, 2009, 113 (19) : 4637 - 4645
  • [42] Assessment of Tumor Lysis Syndrome in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax in the Clinical Trial and Post-Marketing Settings
    Seymour, John F.
    Gribben, John G.
    Davids, Matthew S.
    Mato, Anthony
    Sharman, Jeff P.
    Cyr, Aimee
    Bartkus, Cynthia
    Pena, German
    Boyer, Michelle
    Sharmokh, Simon
    Rosenberg, Tanya S.
    Wierda, William G.
    BLOOD, 2020, 136
  • [43] Contribution of Cyclin Dependent Kinase Inhibitor 1A Genotypes to Childhood Acute Lymphocytic Leukemia Risk in Taiwan
    Chen, Chao-chun
    Tsai, Chung-lin
    Pei, Jen-sheng
    Tzeng, Huey-en
    Hsu, Pei-chen
    Cheng, Da-chuan
    Lin, Jiunn-cherng
    Tsai, Chia-wen
    Bau, Da-tian
    Chang, Wen-shin
    CANCER GENOMICS & PROTEOMICS, 2025, 22 (01) : 46 - 54
  • [44] Tumor lysis syndrome: An uncommon complication of fludarabine therapy of chronic lymphocytic leukemia
    Cheson, BD
    Frame, JN
    Vena, D
    Quashu, N
    Sorensen, JM
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) : 2313 - 2320
  • [45] TUMOR LYSIS SYNDROME AFTER TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA WITH FLUDARABINE
    MONTALBAN, C
    LIANO, F
    AGUILERA, A
    POSTGRADUATE MEDICAL JOURNAL, 1994, 70 (827) : 651 - 652
  • [46] Ibrutinib-associated tumor lysis syndrome in a patient with chronic lymphocytic leukemia
    Kaur, Varinder
    Mehta, Paulette
    Johnsurd, Joyce
    Govindarajan, Rangaswamy
    BLOOD, 2014, 124 (23) : 3503 - 3505
  • [47] Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patients
    Fabre, Claire
    Gobbi, Marco
    Ezzili, Cyrine
    Zoubir, Mustapha
    Sablin, Marie-Paule
    Small, Karen
    Im, Ellie
    Shinwari, Nabeegha
    Zhang, Da
    Zhou, Honghong
    Le Tourneau, Christophe
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (05) : 1057 - 1064
  • [48] Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patients
    Claire Fabre
    Marco Gobbi
    Cyrine Ezzili
    Mustapha Zoubir
    Marie-Paule Sablin
    Karen Small
    Ellie Im
    Nabeegha Shinwari
    Da Zhang
    Honghong Zhou
    Christophe Le Tourneau
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1057 - 1064
  • [49] Risk Factors for Richter Syndrome in Chronic Lymphocytic Leukemia
    Sameer A. Parikh
    Tait D. Shanafelt
    Current Hematologic Malignancy Reports, 2014, 9 : 294 - 299
  • [50] Risk Factors for Richter Syndrome in Chronic Lymphocytic Leukemia
    Parikh, Sameer A.
    Shanafelt, Tait D.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (03) : 294 - 299
12345